Updated Jul 16, 2026
Bleil Lynn Dorsey has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-27 | FOLD | AMICUS THERAPEUTICS, INC. | D — Derivative transaction | 113.9K | $14.50 | $1.65M |
| 2025-06-05 | FOLD | AMICUS THERAPEUTICS, INC. | A — Grant or award | 20.4K | $0.00 | |
| 2024-11-04 | SRCL | STERICYCLE INC | D — Derivative transaction | 2.5K | $62.00 | $153K |
Bleil Lynn Dorsey is a corporate insider — currently tracked as Insider of AMICUS THERAPEUTICS, INC. (FOLD). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bleil Lynn Dorsey profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.